Literature DB >> 36130575

Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative case.

Yoshio Araki1, Kinya Yokoyama1, Kenji Uda1, Fumiaki Kanamori1, Michihiro Kurimoto1, Yoshiki Shiba1, Takashi Mamiya1, Kai Takayanagi1, Kazuki Ishii1, Masahiro Nishihori1, Kazuhito Takeuchi1, Kuniaki Tanahashi1, Yuichi Nagata1, Yusuke Nishimura1, Sho Okamoto2, Masaki Sumitomo3, Takashi Izumi1, Ryuta Saito1.   

Abstract

BACKGROUND: Transient neurological deficits (TNDs) develop after cerebral revascularization in patients with moyamoya disease (MMD). The authors report a rare pediatric MMD case with extensive decreased cerebral blood flow (CBF) and prolonged TNDs after combined revascularization. OBSERVATIONS: A 9-year-old boy presented with transient left upper limb weakness, and MMD was diagnosed. A right-sided combined surgery was performed. Two years after the surgery, frequent but transient facial (right-sided) and upper limb weakness appeared. The left internal carotid artery terminal stenosis had progressed. Therefore, a left combined revascularization was performed. The patient's motor aphasia and right upper limb weakness persisted for approximately 10 days after surgery. Magnetic resonance angiography showed that the direct bypass was patent, but extensive decreases in left CBF were observed using single photon emission tomography. With adequate fluid therapy and blood pressure control, the neurological symptoms eventually disappeared, and CBF improved. LESSONS: The environment of cerebral hemodynamics is heterogeneous after cerebral revascularization for MMD, and the exact mechanism of CBF decreases was not identified. TNDs are significantly associated with the onset of stroke during the early postoperative period. Therefore, appropriate treatment is desired after determining complex cerebral hemodynamics using CBF studies.

Entities:  

Keywords:  cerebral blood flow; combined revascularization surgery; moyamoya disease; pediatrics; transient neurological deficits

Year:  2022        PMID: 36130575      PMCID: PMC9379648          DOI: 10.3171/CASE21628

Source DB:  PubMed          Journal:  J Neurosurg Case Lessons        ISSN: 2694-1902


Moyamoya disease (MMD) is characterized by stenoocclusive changes at the terminus of the bilateral internal carotid artery (ICA) and the development of basal collateral networks.[1,2] Direct and indirect combined revascularization surgeries were established for effective treatment, and these surgeries comprise a superficial temporal artery (STA) middle cerebral artery (MCA) bypass for direct bypass and the placement of the vascularized pedicle using temporal muscle, dura mater, and periosteum for indirect bypass. Evidence shows that these treatments reduce cerebral ischemia and the risk of future hemorrhagic events.[3-6] However, transient neurological deficits (TNDs), such as numbness or weakness in the extremities, aphasia, and dysarthria, are well-recognized major events that develop in the early postoperative period.[7-10] Cerebral blood flow (CBF) studies indicated that these symptoms were caused by focal hyperperfusion as a result of rapid increase in blood flow due to the direct bypass.[11-13] However, CBF studies also showed that TNDs may occur in patients without focal hyperperfusion, and the pathophysiology of TNDs was not fully elucidated.[8,10,14] Notably, a focal reduction in CBF after combined revascularization for pediatric MMD was rarely reported.[15] We report a pediatric patient who had prolonged transient motor aphasia and motor weakness in the upper extremities as TNDs after combined revascularization with decreased CBF.

Illustrative Case

A 9-year-old right-handed boy presented to a physician with reports of transient left upper limb weakness. A diagnosis of MMD was suspected on magnetic resonance angiography (MRA), and digital subtraction angiography (DSA) was subsequently performed. MMD was diagnosed based on the criteria of the Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis (Fig. 1A).[16] No significant ischemic lesions were observed on fluid-attenuated inversion recovery (FLAIR) using magnetic resonance imaging (MRI) (Fig. 1B). However, single photon emission computed tomography (SPECT) showed a marked decrease in CBF within the right MCA territory (Fig. 1C). Therefore, antiplatelet therapy was started. Direct and indirect combined revascularization on the right side was implemented. SPECT approximately 2 weeks after surgery showed improvement in the CBF of the right MCA territory. The patient was discharged without any TNDs or new strokes during the postoperative course.
FIG. 1.

Images taken during the onset of symptoms in a 9-year-old boy who initially presented with transient left upper limb weakness. A: Cerebral angiography showed mild stenosis of the right ICA terminal and development of Moyamoya vessels. B: No significant ischemic lesions were observed on FLAIR using MRI. C: SPECT showed a marked decrease in the CBF in the right MCA territory.

Images taken during the onset of symptoms in a 9-year-old boy who initially presented with transient left upper limb weakness. A: Cerebral angiography showed mild stenosis of the right ICA terminal and development of Moyamoya vessels. B: No significant ischemic lesions were observed on FLAIR using MRI. C: SPECT showed a marked decrease in the CBF in the right MCA territory. Approximately 2 years after surgery was performed on the right side, the patient developed an intermittent weakness of the right side of the face and upper limbs. MRA revealed that the stenosis of the left ICA terminal had progressed without posterior cerebral artery (PCA) involvement (Fig. 2A, arrow). No new cerebral ischemic lesions were found on FLAIR (Fig. 2B), but left cerebral revascularization and fluid replacement treatment were urgently planned because of the high frequency of transient ischemic attacks (TIAs).
FIG. 2.

Approximately 2 years after the patient had surgery on the right side, transient weakness of the right side of his face and upper limbs began to reappear frequently. A: MRA shows progression of stenosis of the left ICA terminal without PCA involvement (white arrow). B: No new cerebral ischemic lesions were found on FLAIR.

Approximately 2 years after the patient had surgery on the right side, transient weakness of the right side of his face and upper limbs began to reappear frequently. A: MRA shows progression of stenosis of the left ICA terminal without PCA involvement (white arrow). B: No new cerebral ischemic lesions were found on FLAIR. Left cerebral revascularization, consisting of STA-MCA single bypass plus encephalo-myo-synangiosis of the temporal region and encephalo-galeo-periosteal-synangiosis of the frontal region, was performed via two craniotomies. The precentral artery was selected as the recipient of the direct bypass, and the time required for the anastomosis was 16 minutes. The amount of bleeding was 250 mL, but the patient’s hemoglobin level did not drop below 10 g/dL. Therefore, a blood transfusion was not required. No problematic findings were found on computed tomography (CT) immediately after surgery, but the patient developed symptoms of motor aphasia and right upper limb paresis. Because there was a possibility of cerebral ischemia and focal hyperperfusion, the patient was treated with blood pressure control and fluid therapy. The symptoms remained on postoperative day (POD) 1. However, diffusion-weighted imaging was negative on MRI, and the bypass was patent on MRA (Fig. 3A, arrow). SPECT was performed on POD 3 because the patient had prolonged neurological symptoms, and extensive decreases in CBF in the left MCA territory were observed (Fig. 3B). A CT at the same time as the SPECT showed mild swelling of the temporal muscular flap that was placed via the indirect method, but there was no apparent brain compression. Another MRI was performed on POD 4, but there were no cerebral ischemic lesions (Fig. 3C), and the bypass was patent on the MRA (Fig. 3D, arrow). Antiplatelet therapy was resumed. The patient’s neurological symptoms, including motor aphasia and left upper limb paresis, persisted until POD 8 and then started to improve. Figure 4 shows SPECT on POD 10; CBF of the left MCA territory was improved. Thepatient’s neurological symptoms completely resolved on POD 14, and the patient was discharged from the hospital. A recheck DSA approximately 1 year after surgery showed good revascularization effect in the left STA and in the other external carotid arterial systems (Fig. 5).
FIG. 3.

Left cerebral revascularization, consisting of STA-MCA single bypass plus encephalo-myo-synangiosis of the temporal region and encephalo-galeo-periosteal-synangiosis of the frontal region, was performed via two craniotomies. The patient developed motor aphasia and right upper limb aphasia immediately after surgery. A: MRA from POD 1 shows the patent bypass (arrow). B: SPECT on POD 3 shows extensive CBF decreases in the left MCA territory. C: MRI/MRA reexamination on POD 4 shows no acute cerebral infarction, and the bypass remained patent (D, arrow).

FIG. 4.

The neurological symptoms of motor aphasia and left upper limb paresis persisted to POD 8 and then started to improve. SPECT on POD 10 shows improvement of the CBF of the left MCA territory. A: Ventricular level. B: Centrum Semiovale level.

FIG. 5.

DSA findings approximately 1 year after surgery show a good revascularization effect from the left STA and in other external carotid arterial systems. A: Right side. B: Left side.

Left cerebral revascularization, consisting of STA-MCA single bypass plus encephalo-myo-synangiosis of the temporal region and encephalo-galeo-periosteal-synangiosis of the frontal region, was performed via two craniotomies. The patient developed motor aphasia and right upper limb aphasia immediately after surgery. A: MRA from POD 1 shows the patent bypass (arrow). B: SPECT on POD 3 shows extensive CBF decreases in the left MCA territory. C: MRI/MRA reexamination on POD 4 shows no acute cerebral infarction, and the bypass remained patent (D, arrow). The neurological symptoms of motor aphasia and left upper limb paresis persisted to POD 8 and then started to improve. SPECT on POD 10 shows improvement of the CBF of the left MCA territory. A: Ventricular level. B: Centrum Semiovale level. DSA findings approximately 1 year after surgery show a good revascularization effect from the left STA and in other external carotid arterial systems. A: Right side. B: Left side.

Discussion

Observations

We report a pediatric patient with MMD who experienced a paradoxical symptomatic CBF decrease after combined revascularization surgery. Although a few cases of hypoperfusion after revascularization in adult MMD cases were reported, this report is the first pediatric case.[14,17,18] Numerous studies were performed on the development of TNDs and the risk of stroke associated with focal hyperperfusion after direct bypass for adult MMD.[11-13,19,20] The rapid increase in focal CBF due to direct bypass may have a temporary effect on the function of the cerebral cortex around the anastomotic site. However, the pathophysiology of focal CBF changes is unique because some patients do not have obvious focal hyperperfusion; these types of cases were evaluated in CBF studies of postoperative TND cases.[8,10,21] There are reports of two adult MMD cases with vasogenic edema without obvious hyperperfusion after STA-MCA bypass surgery.[22] This research group also reported cases of TNDs caused by vasogenic edema and global hypoperfusion.[17] Mukerji et al.[14] analyzed the cause of TNDs in the early postoperative period using an intraoperative flow probe, and they reported that the affected autoregulation caused a competing flow between the cerebral vessels and the bypass flow, which resulted in hypoperfusion. These reports suggest that the environment of cerebral circulation is heterogeneous after cerebral revascularization for MMD. This speculation was also supported by the various changes observed on postoperative MRI FLAIR images. Hamano et al.[8] stated that the cortical hyperintensity belt sign in FLAIR was associated with postoperative TNDs, but the authors included hyperperfusion and hypoperfusion in their CBF study. Our group reported that TNDs were significantly associated with the development of stroke during the early postoperative period.[7] Therefore, appropriate treatment is desired for complicated postoperative cerebral hemodynamics, and a timely analysis of cerebral hemodynamics using CBF studies, such as SPECT, is a promising appropriate and timely treatment.[23] Electroencephalography may be useful to capture changes in the cerebral hemodynamics in the acute phase after combined surgery, other than SPECT and perfusion CT/MRI.[24] In addition to indocyanine green video angiography, donor/recipient flow probe measurements may be effective tools to provide further insight.[10,14] The cause of TNDs after combined revascularization in patients is likely due to a wide range of CBF decreases. However, the exact mechanism of the decreases in CBF was not identified. The watershed shift phenomenon is a potential etiology.[15,18,25,26] Tashiro et al.[17] found that this phenomenon occurred in 10.9% of adult patients with MMD after STA-MCA bypass surgery. The anastomosed STA-MCA bypass flow conflicts with the recipient MCA flow in the proposed pathology, and the original MCA perfusion territory showed low perfusion during a CBF study due to the shift of the watershed territory. SPECT was not performed immediately before surgery in this case, and it cannot be compared with postoperative SPECT. Therefore, there is a lack of information to explain the watershed shift phenomenon. Notably, one case had effects other than the effects secondary to the changes in flow due to direct bypass and decreases in the CBF due to a direct compression of the brain because of swelling of the temporalis muscle flap that was placed during indirect surgery.[27] This fact should be recognized because combined revascularization mainly uses the temporalis muscle. There was no swelling of the patient’s temporalis muscle flap on the CT performed simultaneously with POD 3 SPECT, but the patient had marked decreases in CBF. Because TNDs may be caused by direct bypass flow and CBF decreases, the relationship between indirect procedures and TNDs is interesting. Previous studies by our group demonstrated that compression of the temporalis muscle flap that is used in indirect surgery was significantly associated with TNDs.[28] We revealed the relationship between the sulcal hyperintensity sign on FLAIR images after indirect surgery and the occurrence of TNDs.[29] Sakamoto et al.[30] reported that TNDs were observed more frequently in patients receiving indirect surgery than patients receiving direct bypass. Although these previous studies did not verify the fluctuations in CBF, the results suggested that the causes of TNDs were complex. Because the temporal muscle and galea that are placed on the brain surface via indirect surgery are not present in the physiological environment, these techniques may cause inflammation and head trauma.[31] MRI FLAIR revealed that the sulcal hyperintensity signals were due to changes in the composition of cerebrospinal fluid and development of inflammatory responses.[32] These findings support the hypothesis that inflammation is an etiology of TNDs. However, the authors also noted that focal hyperperfusion on SPECT and TNDs after combined surgery was not a significant pathological condition, but it was similar to posterior reversible encephalopathy syndrome and vascular edema.[8,33] Rapid changes in focal CBF due to direct bypass and direct stimulation of the brain in combined revascularization and changes in the composition of cerebrospinal fluid due to indirect surgery may be microenvironments that induce an impaired blood–brain barrier and endothelial injuries.[34] This environment may induce hyperpermeability of the vasculature, which results in CBF decreases and intravascular dehydration. From a radiological perspective, the MCA appeared spastic after surgery compared to the other vascular systems in the MRA findings (Fig. 3A). Therefore, the pathophysiology of decreased CBF and TNDs may also be related to the pathology of reversible cerebral vasoconstriction syndrome caused by endothelial injury.[35] The policy of our institution on preoperative infusion and oral antiplatelet drugs should be described. The Anesthesiology Department instructs patients to fast after dinner the day before surgery. Patients receive intravenous extracellular fluid at a maintenance dose for volume replacement to prevent dehydration from the afternoon of the day before surgery. We administer aspirin preoperatively in most patients as an antiplatelet therapy. Aspirin administration should be discontinued on the third day before surgery because of the risk of excessive intraoperative bleeding and postoperative bleeding, except for patients who are likely to have severe cerebral ischemia before surgery.[36] The details regarding blood pressure and fluid therapy should be valuable lessons from this case. First, the preoperative baseline blood pressure of this 9-year-old patient was 110/70 mm Hg, which was normotensive. Ischemic attacks may be avoided by maintaining preoperative baseline blood pressure during the perioperative period of cerebral revascularization for MMD.[37] The autoregulatory response to hypotension is definitely lower in children than adults, which increases its importance.[38] Lee et al.[39] investigated intraoperative functional autoregulation using near-infrared spectroscopy and showed that postoperative TIA was more frequent when it was impaired. However, they could not set a goal for postoperative target blood pressure because of age and individual differences in autoregulation. Therefore, we set the lower limit of the perioperative blood pressure control target for patients with ischemic-type pediatric MMD as the preoperative baseline value. Only a few survey results in adults were reported in the setting of the upper limit of postoperative blood pressure.[40] According to these results, the upper limit of systolic blood pressure was approximately 130 to 140 mm Hg. However, we adopted an additional 20% of the preoperative value because of the lower baseline blood pressure reference values in children than adults and because postoperative hyperperfusion syndrome and cerebral hemorrhage are definitely less common in children than in adults.[41] Fluid management is also extremely important for prevention of postoperative cerebral ischemia in MMD. Sufficient intravenous administration of extracellular fluid avoids postoperative hypotension and hypovolemia.[40] Unlike adults, pediatric patients receive 1 to 1.5 times the normal maintenance rate converted by body weight.[42] We do not measure central venous pressure in our routine. However, the total balance among oral intake, total infusion volume, and urine output is controlled to avoid negative values. Blood pressure control and fluid therapy should always be administered at least during the appearance of TNDs. Our previous study showed that the average duration of appearance of TNDs was 8.2 days (range 2 to 16).[10] Notably, the postoperative inflammatory response peaked at 2 to 3 days and normalized at approximately 7 days. Management should be strengthened during this time because extracellular fluid leakage causes hypotension and intravascular dehydration. The blood pressure management and fluid therapy strategy prevented the progression of stroke to a unique postoperative CBF condition in this case. With the discovery of extensive CBF decreases in SPECT on POD 3, the permissive hypertension blood pressure management strategy was certainly considered. However, we did not choose the intentional hypertension policy because of the safety issues of continuous hypertension administration to pediatric patients and the lack of prior literature on its use. Sufficient fluid therapy was provided instead.

Lessons

The treatment strategy for these cases is important. However, no progression to stroke was observed in this patient after he received sufficient fluid replacement and normotensive blood pressure control, and the imaging findings and the patient’s symptoms eventually resolved. In situations in which the pathophysiology has not been fully elucidated, strict perioperative management may be required with frequent CBF studies to manage cerebral ischemia and focal hyperperfusion.

Disclosures

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Author Contributions

Conception and design: Araki, Uda, Kurimoto, Shiba, Takayanagi, Nishihori. Acquisition of data: Araki, Yokoyama, Uda, Kanamori, Kurimoto, Shiba, Mamiya, Takayanagi, Takeuchi, Okamoto. Analysis and interpretation of data: Araki, Kurimoto, Shiba, Mamiya, Takayanagi, Tanahashi, Saito. Drafting the article: Araki, Shiba, Takayanagi. Critically revising the article: Uda, Tanahashi, Nishimura, Izumi. Reviewed submitted version of manuscript: Yokoyama, Uda, Ishii, Tanahashi, Nagata, Nishimura, Saito. Approved the final version of the manuscript on behalf of all authors: Araki. Statistical analysis: Kurimoto. Administrative/technical/material support: Nishihori, Nagata, Sumitomo. Study supervision: Nishihori, Okamoto, Izumi, Saito.
  41 in total

1.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

2.  Brain Compression by Encephalo-Myo-Synangiosis is a Risk Factor for Transient Neurological Deficits After Surgical Revascularization in Pediatric Patients with Moyamoya Disease.

Authors:  Fumiaki Kanamori; Yoshio Araki; Kinya Yokoyama; Kenji Uda; Masahiro Nishihori; Takashi Izumi; Sho Okamoto; Toshihiko Wakabayashi
Journal:  World Neurosurg       Date:  2019-09-25       Impact factor: 2.104

3.  Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

4.  Effect of Sevoflurane Postconditioning on the Incidence of Symptomatic Cerebral Hyperperfusion After Revascularization Surgery in Adult Patients with Moyamoya Disease.

Authors:  Hyun-Kyu Yoon; Hyongmin Oh; Hyung-Chul Lee; Won-Sang Cho; Jeong Eun Kim; Jae Won Park; Hongyoon Choi; Hee-Pyoung Park
Journal:  World Neurosurg       Date:  2019-11-14       Impact factor: 2.104

5.  Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.

Authors:  Hiroyuki Sakata; Miki Fujimura; Shunji Mugikura; Kenichi Sato; Teiji Tominaga
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-05-06       Impact factor: 2.136

6.  Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial.

Authors:  Susumu Miyamoto; Takashi Yoshimoto; Nobuo Hashimoto; Yasushi Okada; Ichiro Tsuji; Teiji Tominaga; Jyoji Nakagawara; Jun C Takahashi
Journal:  Stroke       Date:  2014-03-25       Impact factor: 7.914

7.  Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease.

Authors:  Hyun Gi Kim; Seung-Koo Lee; Jung-Dong Lee
Journal:  J Neurosurg Pediatr       Date:  2016-10-07       Impact factor: 2.375

Review 8.  Moyamoya Disease: Treatment and Outcomes.

Authors:  Tackeun Kim; Chang Wan Oh; Jae Seung Bang; Jeong Eun Kim; Won-Sang Cho
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

9.  Clinical Features, Surgical Treatment, and Long-Term Outcome of a Multicenter Cohort of Pediatric Moyamoya.

Authors:  Jun Zheng; Le-Bao Yu; Ke-Fang Dai; Yan Zhang; Rong Wang; Dong Zhang
Journal:  Front Neurol       Date:  2019-01-22       Impact factor: 4.003

10.  Paradoxical association of symptomatic cerebral edema with local hypoperfusion caused by the 'watershed shift' after revascularization surgery for adult moyamoya disease: a case report.

Authors:  Jin Yu; Miao Hu; Lei Yi; Keyao Zhou; Jianjian Zhang; Jincao Chen
Journal:  Ther Adv Neurol Disord       Date:  2019-09-25       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.